Fidelity International’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-554,177
Closed -$77.6M 993
2018
Q4
$77.6M Buy
554,177
+67,737
+14% +$10.3M 0.14% 180
2018
Q3
$83.1M Sell
486,440
-104,294
-18% -$17.5M 0.12% 187
2018
Q2
$102M Buy
+590,734
New +$88.8M 0.15% 159
2017
Q4
Sell
-27,328
Closed -$2.52M 538
2017
Q3
$2.52M Sell
27,328
-18,786
-41% -$1.46M 0.01% 437
2017
Q2
$3.7M Hold
46,114
0.01% 412
2017
Q1
$1.94M Buy
+46,114
New +$1.9M 0.01% 468

Other funds holding LOXO

Fidelity International's LOXO Position: Q1 2019 in Review

Fidelity International sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 554,177 shares — an estimated $77.6M sold.

Fidelity International first reported a position in LOXO in Q1 2017 and held it in 6 quarters. The position peaked at $102M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Fidelity International reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Fidelity International sold 554,177 Loxo Oncology, Inc shares in Q1 2019, an estimated $77.6M.
  • Fidelity International first reported a position in Loxo Oncology, Inc in Q1 2017 and held it in 6 quarters.
  • Fidelity International's Loxo Oncology, Inc position peaked at $102M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Fidelity International's 13F filing for Q1 2019, filed 13 May 2019.